Luye Pharma Group (HKG:2186) entered into agreements with a subscriber for the conditional issuance of bonds worth $150 million, according to a Wednesday filing with the Hong Kong bourse.
Two tranches of $100 million and $50 million convertible bonds will be issued. Both tranches have a 5.85% interest rate and will mature in 2025. The proceeds will be used to refinance debt and support research and development.
These bonds can be converted into shares at HK$3.67 per share. The amount represents about 8.44% of the current issued share capital. The transaction remains subject to conditions.
The share prices of the pharmaceutical were down by almost 2% in recent trading.
Price (HKD): $3.01, Change: $-0.050, Percent Change: -1.63%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。